Profitability Ratios
| Ratio |
Value |
| GP Margin |
38.8% |
| EBIT Margin |
-9.1% |
| EBITDA Margin |
0.2% |
| Operating Margin |
-9.1% |
| Pretax Margin |
-15.2% |
| Cont. Ops Margin |
-14.9% |
| Net Margin |
-14.9% |
| Bottom Line Margin |
-14.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
4.26 |
| Quick Ratio |
3.94 |
| Solvency Ratio |
-0.077 |
| Cash Ratio |
1.81 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.08 |
| Forward PEG |
-0.08 |
| Price/Book |
0.36 |
| Price/Sales |
0.41 |
| Price/FCF |
-13.83 |
| Price/Op Cash Flow |
57.61 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3473 |
| Debt/Equity |
0.5645 |
| Debt/Capital |
0.3608 |
| Long-Term Debt/Capital |
0.3260 |
| Financial Leverage |
1.63 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.50 |
| Operating Cash Flow Ratio |
0.059 |
| Operating Cash Flow/Sales |
0.7% |
| Free Cash Flow/Operating Cash Flow |
-416.4% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.47 |
| Interest Coverage |
-17.6070 |
| Short-Term Operating Cash Flow Coverage |
1.10 |
| Operating Cash Flow Coverage |
0.01 |
| Capital Expenditure Coverage |
0.19 |
| Dividend + Capital Expenditure Coverage |
0.19 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
28.39 |
| EPS |
-4.216 |
| Debt/Share |
18.5803 |
| Cash/Share |
6.23 |
| Book Value/Share |
32.65 |
| Tangible BV/Share |
1.00 |
| Equity/Share |
32.65 |
| Operating Cash Flow/Share |
0.204 |
| Capital Expenditure/Share |
1.054 |
| FCF/Share |
-0.850 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.980 |
| Earnings Before Tax/EBIT |
1.669 |
| Price/Fair Value |
0.36 |
| Debt/Market Cap |
1.3590 |
| Effective Tax Rate |
2.0% |
| Enterprise Value Multiple |
351.84 |
NEO - NeoGenomics, Inc.